Literature DB >> 10895036

Neonatal diabetes: new insights into aetiology and implications.

J P Shield1.   

Abstract

Neonatal diabetes mellitus (NDM) is defined as hyperglycaemia occurring in the first few weeks of life. It can be either transient (TNDM) or permanent (PNDM), and until recently, little was known about the condition. A cohort of 30 infants with a history of TNDM has been studied, and findings have suggested that NDM does not have the same aetiology as classical type 1 childhood diabetes. Uniparental isodisomy of chromosome 6 and an unbalanced duplication of paternal chromosome 6 have both been described as a genetic basis for TNDM in over 75% of the cases. In addition, cerebellar hypoplasia and Walcott-Rallison syndrome have been associated with PNDM, suggesting an autosomal recessive inheritance pattern; furthermore, a mutation in the gene insulin promoter factor 1 has been identified as a cause of pancreatic agenesis in PNDM. In the long term, TNDM may reduce beta cell functional capacity and present a predisposition to type 2 diabetes mellitus. Copyright 2000 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10895036     DOI: 10.1159/000053198

Source DB:  PubMed          Journal:  Horm Res        ISSN: 0301-0163


  17 in total

Review 1.  New insights into the genetics of neonatal diabetes.

Authors:  Constantin Polychronakos
Journal:  Rev Endocr Metab Disord       Date:  2003-03       Impact factor: 6.514

2.  Neonatal hyperglycaemia: a challenging diagnosis.

Authors:  Sara Noéme Prado; Raquel Amaral; Teresa Tomé; Ana Bettencourt; Filomena Pinto; Tiago Rocha
Journal:  BMJ Case Rep       Date:  2010-07-21

Review 3.  Paternal uniparental isodisomy of chromosome 6 causing a complex syndrome including complete IFN-gamma receptor 1 deficiency.

Authors:  Carolina Prando; Stéphanie Boisson-Dupuis; Audrey V Grant; Xiao-Fei Kong; Jacinta Bustamante; Jacqueline Feinberg; Ariane Chapgier; Yoann Rose; Lucile Jannière; Elena Rizzardi; Qiuping Zhang; Catherine M Shanahan; Louis Viollet; Stanislas Lyonnet; Laurent Abel; Ezia Maria Ruga; Jean-Laurent Casanova
Journal:  Am J Med Genet A       Date:  2010-03       Impact factor: 2.802

4.  Aetiological heterogeneity of asymptomatic hyperglycaemia in children and adolescents.

Authors:  E Feigerlová; S Pruhová; L Dittertová; J Lebl; D Pinterová; K Kolostová; M Cerná; O Pedersen; T Hansen
Journal:  Eur J Pediatr       Date:  2006-04-07       Impact factor: 3.183

5.  Functional analysis of six Kir6.2 (KCNJ11) mutations causing neonatal diabetes.

Authors:  Christophe A J Girard; Kenju Shimomura; Peter Proks; Nathan Absalom; Luis Castano; Guiomar Perez de Nanclares; Frances M Ashcroft
Journal:  Pflugers Arch       Date:  2006-09-22       Impact factor: 3.657

6.  Neonatal diabetes with hyperchylomicronemia.

Authors:  Zehra Aycan; Merih Berberoğlu; Gönül Ocal; Nilgün Altundas; Pelin Adiyaman; Olcay Evliyaoğlu
Journal:  Indian J Pediatr       Date:  2002-12       Impact factor: 1.967

Review 7.  Neonatal diabetes mellitus.

Authors:  Lydia Aguilar-Bryan; Joseph Bryan
Journal:  Endocr Rev       Date:  2008-04-24       Impact factor: 19.871

8.  An assessment of pancreatic endocrine function and insulin sensitivity in patients with transient neonatal diabetes in remission.

Authors:  J P H Shield; I K Temple; M Sabin; D Mackay; D O Robinson; P R Betts; D J Carson; H Cavé; D Chevenne; M Polak
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2004-07       Impact factor: 5.747

9.  DNA hypomethylation, transient neonatal diabetes, and prune belly sequence in one of two identical twins.

Authors:  Lene Bjerke Laborie; Deborah J G Mackay; I Karen Temple; Anders Molven; Oddmund Søvik; Pål Rasmus Njølstad
Journal:  Eur J Pediatr       Date:  2009-06-13       Impact factor: 3.183

10.  Sulfonylurea therapy in two Korean patients with insulin-treated neonatal diabetes due to heterozygous mutations of the KCNJ11 gene encoding Kir6.2.

Authors:  Min Sun Kim; Sun Young Kim; Gu Hwan Kim; Han Wook Yoo; Dong Whan Lee; Dae Yeol Lee
Journal:  J Korean Med Sci       Date:  2007-08       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.